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Abstract
Although the protective functions by T helper 17 (Th17) cytokines against extracellular bacterial and fungal infection have
been well documented, their importance against intracellular bacterial infection remains unclear. Here, we investigated the
contribution of Th17 responses to host defense against intracellular bacteria Listeria monocytogenes and found that Th17
cell generation was suppressed in this model. Unexpectedly, mice lacking both p35 and EBI3 cleared L. monocytogenes as
efficiently as wild-type mice, whereas p35-deficient mice failed to do so. Furthermore, both innate cells and pathogen-
specific T cells from double-deficient mice produced significantly higher IL-17 and IL-22 compared to wild-type mice. The
bacterial burden in the liver of double-deficient mice treated with anti-IL-17 was significantly increased compared to those
receiving a control Ab. Transfer of Th17 cells specific for listeriolysin O as well as administration of IL-17 and IL-22
significantly suppressed bacterial growth in p35-deficient mice, indicating the critical contribution of Th17 responses to host
defense against the intracellular pathogen in the absence of IL-12 and proper Th1 responses. Our findings unveil a novel
immune evasion mechanism whereby the intracellular bacteria exploit IL-27EBI3 to suppress Th17-mediated protective
immunity.
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Introduction
The generation of pathogen-specific T cell responses is essential
for the clearance of infectious agents. This involves the differen-
tiation of naı¨ve T cells into distinct pathogen-specific helper T cell
lineages in a process that largely depends on the cytokine milieu
created by innate immune cells upon their activation. Among
these innate cytokines, the IL-12 family plays a pivotal role during
the differentiation of helper T cells by promoting or inhibiting the
lineage program of Th1 or Th17 cells. IL-12 and Th1 responses
mediate protective immunity against intracellular pathogens such
as Mycobacterium tuberculosis, Francisella tularemia, and Listeria monocy-
togenes [1,2]. Conversely, the production of IL-23 and the
generation of Th17 responses are thought to mediate host defense
against extracellular bacteria such as Staphylococcus aureus, Klebsiella
pneumoniae, and Citrobacter rodentum [3,4,5,6], as well as fungi such as
Candida albicans and Pneumocystis carnii [7,8]. The function of Th17
cells following intracellular bacterial infection is less clear.
The IL-12 gene family consists of p35, p40, p19, p28 and
Epstein-Barr virus-induced 3 (EBI3). Different combination of two
gene-products from this family results in the production of four
cytokines: IL-12 (p35/p40), IL-23 (p19/p40), IL-27 (p28/EBI3)
and IL-35 (p35/EBI3) [9,10]. IL-12, IL-23 and IL-27 are
produced by antigen-presenting cells such as dendritic cells (DC)
and macrophages, whereas IL-35 is primarily produced by
regulatory T cells [9,10]. IL-12 is essential for promoting IFNc
production by innate cells such as NK and NKT cells following
viral and bacterial infections. The IL-12 family also impacts
adaptive T cell responses where IL-12 promotes Th1 generation
and IL-23 promotes Th17 cells. IL-27 is thought to mediate the
early phase of Th1 responses [11]. For instance, mice deficient in
IL-27Ra exhibit reduced Th1 responses following infection with
intracellular pathogens such as Listeria monocytogenes and Leishmania
major [12,13]. In contrast, others have shown that the IL-27
receptor signal is not required for Th1 polarization but rather
inhibits IFNc production by CD4+ T cells in an animal model of
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Toxoplasma gondii infection [14]. IL-27 has also been shown to
suppress Th17 differentiation and Th17-mediated tissue inflam-
mation [15,16], probably by inducing the expression of PD-L1 on
T cells [17]. More recently, it has been demonstrated that IL-27
drives the differentiation of IL-10 producing CD4+ T cells
[18,19,20], suggesting anti-inflammatory function of this cytokine.
Thus, IL-12 family of cytokines are involved in complex and often
opposing roles in the development of helper T cell responses
during infection and inflammation.
Listeria monocytogenes (Lm) is a Gram-positive, intracellular
bacterium that can cause meningitis and encephalitis in im-
mune-compromised individuals as well as reproductive issue in
pregnant women [21]. The host defense against Lm involves a
complex network of innate and adaptive immune cells. Following
infection, Lm promptly triggers a series of innate immune cell
activation where IFNc produced mainly by natural killer (NK)
cells contributes to initial resistance then triggers the induction of
TNF-a and iNOS-producing dendritic cells (Tip-DC) that can
control bacterial growth in vivo. In addition, neutrophils and
macrophages are recruited and mediate killing of the intracellular
pathogen. Finally, pathogen specific CD4+ T cells and CD8+ T
cells are generated and mediate efficient bacterial clearance and
recall responses to the pathogen [21]. cd T cells may also be
involved in an innate capacity as mice deficient in cd T cells are
more susceptible to the Lm infection [22]. In this regard, a recent
study showed that IL-23 mediated activation of IL-17-producing
cd T cells can contribute the resistance against Lm infection
[23,24].
The importance of Th17 responses in the host defense against
extracellular pathogens has been well described, however, whether
Th17 cells and Th17 cytokines play a role against intracellular
pathogen remains unclear. In addition, no study to date has fully
addressed the relative contribution of IL-12 family cytokines
following intracellular bacterial infection. To address these issues,
we investigated anti-Listeria immunity in mice deficient in IL-
12p35, IL-27EBI3, or both. Unexpectedly, our findings uncovered
a dominant negative regulatory role of IL-27EBI3 in the protective
immunity to Lm, especially in the absence of IL-12p35. The
function of EBI3 was, at least in part, mediated by inhibiting the
production of Th17 cytokines.
Results
Innate and helper T cell responses against Listeria
monocytogenes infection
Systemic infection with Lm is known to induce pathogen-
specific Th1 cells. To examine if pathogen-specific Th17 cells are
also generated during infection, we intravenously infected C57BL/
6 mice with Lm expressing ovalbumin (Lm-Ova) [25], and
examined the expression of IL-17 and IFNc by splenic CD4+ T
cells after restimulation with an Lm-specific, MHC II-restricted
peptide (listeriolysin O (LLO)190–201). As expected, intravenous
infection with live Lm-Ova induced a high percentage of IFNc-
producing CD4+ T cells (Figure 1A). By contrast, very few CD4+ T
cells expressed IL-17 in the spleens of the infected mice.
Among the IL-12 family cytokines, IL-23 mediates Th17
immunity while IL-12 and IL-27 induce Th1 and suppress Th17
responses. To determine if the Lm dominant Th1 responses were
due to a preferential induction of IL-12 and IL-27, we examined
the induction of IL-12 family genes in dendritic cells and
macrophages stimulated with lethally irradiated Lm. Importantly,
irradiation induces the inactivation of Lm without affecting
adjuvanticity and immunogenicity [26]. Stimulation of bone
marrow-derived dendritic cells or macrophages with irradiated
Lm induced the expression of Il12a (encoding IL-12p35), Il12b
(encoding IL-12/IL23p40), Il23a (encoding IL-23p19), Ebi3
Figure 1. CD4+ T cell responses and the induction of IL-12
family genes after infection with L. monotytogenes. A, C57BL/6
mice were intravenously infected with 2.56104 Lm-Ova on day 0, and
splenocytes were obtained on day 7. CD4+ T cells expressing IFNc and
IL-17 were measured by intracellular staining after stimulation with
LLO190–201. B and C, Bone marrow-derived DC or macrophages were
stimulated with LPS, Pam3CSK4, or irradiated Lm-Ova for four hours.
Cells were harvested and analyzed for the mRNA expression of IL-12
family genes by using RT-PCR (B, bone marrow-derived DC), or
quantitative real-time PCR analysis (C). Values are mean 6 SD. Data
shown represent two independent experiments.
doi:10.1371/journal.ppat.1003628.g001
Author Summary
There is a considerable gap in our understanding of how
pathogenic intracellular bacteria escape innate and adap-
tive host immunity. Production of IL-12, and subsequently
IFNc, upon infection triggers host immunity that prevents
early dissemination of pathogenic intracellular pathogens.
This is evident in observing the increased susceptibility of
patients with deficiencies in IL-12, IFNc, or their receptors
to pathogenic intracellular bacteria such as Mycobacterium
tuberculosis and Listeria monocytogenes (Lm). Paradoxically,
the regulation of host defense by other members of the IL-
12 family is poorly understood. Through the use of an
animal model of Lm infection, we show that mice lacking
IL-27EBI3 were resistant to Lm infection, even in the
absence of IL-12. Neutralization and adoptive transfer
studies showed that this protection was mediated through
IL-17, IL-22 and Th17 responses. Thus our results identify
IL-27EBI3 as a critical mechanism for immune escape by
Lm in the absence of IL-12-mediated protective immunity.
Furthermore, our work suggests that targeting IL-27EBI3
may represent a novel strategy for the treatment of
bacterial infection in individuals lacking proper IL-12
responses.
EBI3-Mediated Immune Evasion by L. monocytogenes
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(encoding IL-27EBI3) and Il27 (encoding IL-27p28) as efficiently
as LPS stimulation (Figure 1B & C). Together, these data
demonstrate that while all genes in the IL-12 family were induced
upon Lm encounter, only Th1 immunity was induced after
systemic infection with Lm-Ova in vivo.
Increased Listeria-specific Th17 responses in p352/2
EBI32/2 mice
We next sought to address whether the lack of pathogen-specific
Th17 immunity in wild-type mice after Lm-Ova infection was due
to IL-12 and IL-27. To analyze the relative contribution of IL-
12p35 and IL-27EBI3, we first crossed p352/2mice with EBI32/2
to generate p352/2 EBI32/2 mice. Wild-type, p352/2, EBI32/2,
or p352/2EBI32/2 mice were then systemically infected with Lm-
Ova via the intravenous route. Seven days later, we restimulated
splenocytes from the infected mice with LLO190–201 to measure
pathogen-specific CD4+ T cell responses. As expected, we observed
high percentages of IFNc-producing CD4+ T cells (,20%), while
few CD4+ T cells produced IL-17 in the wild-type mice (,0.5%)
(Figure 2A & B). Compared with wild-type mice, the production of
IFNc by LLO-specific CD4+ T cells was greatly diminished in
p352/2 mice. Notably, although the IL-27 may be an inducer of
Th1 responses [12,13], we did not observe any defect in the
percentage of IFNc-producing CD4+ T cells in EBI32/2 mice
(Figure 2A & B). Instead, we observed that the frequency of IL-17-
producing CD4+ T cells in the EBI3-deficient mice was significantly
higher than those of wild-type mice, likely due to the increased
population producing both IFNc and IL-17 among CD4+ T cells
(Figure 2A & B). Notably, compared with p352/2 and EBI32/2mice,
p352/2EBI32/2 mice exhibited a significantly increased frequency of
IL-17+IFNc2 CD4+ T cells (Figure 2A & B). Consequently, the
production of IL-17 and IL-22 by Lm-specific CD4+ T cells was far
higher in the p352/2EBI32/2 mice compared to wild-type mice
(Figure 2C). p352/2 and EBI32/2mice both showed a slight increase
in the frequency of IL-17+ CD4+ T cells, however, the amounts of IL-
17 produced after antigen restimulation were far less than that of
p352/2EBI32/2 mice. Thus, p352/2EBI32/2 mice exhibited
diminished Th1 and enhanced Th17 responses to Lm-Ova infection,
indicating that IL-27EBI3 and IL-12p35 cooperatively suppress the
generation of pathogen-specific Th17 cells after infection.
Activation of CD8+ T cells and innate cells in the absence
of IL-12p35 and/or IL-27EBI3 following L. monocytogenes
infection
To measure the pathogen-specific CD8+ T cell responses to Lm-
Ova, we restimulated splenocytes from infected mice with
SIINFEKL peptide. CD8+ T cells derived from p352/2 mice
and EBI32/2 mice exhibited similar or higher percentages of
IFNc compared to wild-type T cells (Figure 3A). Moreover, the
percentages of Ova-specific MHC I tetramer-positive CD8+ T
cells were significantly higher in p352/2, EBI32/2, and p352/
2EBI32/2 mice compared to wild-type mice (Figure 3B). The
frequencies of CD8+ T cells expressing granzyme B were
comparable among wild-type, p352/2, and p352/2EBI32/2
mice while decreased in EBI32/2 mice (Figure 3A & B). Hence,
the generation of pathogen-specific CD8+ T cells is largely
independent of p35 and EBI3. These results are consistent, in
part, with a previous study showing that IL-12 is not required for
IFNc production but rather inhibits the generation of memory
CD8+ T cells [27]. By contrast, we observed that the amounts of
IL-17 and IL-22 produced by CD8+ T cells were remarkably
higher in p352/2EBI32/2 mice than those in the wild-type
(Figure 3C). Hence, in the absence of IL-12p35 and IL-27EBI3,
systemic Lm-Ova infection triggers increased production of IL-17
and IL-22 by pathogen-specific CD8+ T cells.
To further examine the regulation of host defensive immunity
by the cytokines of IL-12 family, we analyzed the activation of
innate immune cells during the early phase of Lm infection. IL-12
triggers IFNc production in NK cells and NKT cells which is
critical for the activation of innate cells and the prevention of Lm
propagation [28]. Consistent with this notion, we observed a
significant reduction of IFNc-producing NKT cells and NK cells
in p352/2 mice as well as in p352/2EBI32/2 mice infected with
Lm-Ova (Figure 4A). The percentages of IFNc-producing NKT
cells and NK cells in EBI32/2 mice were comparable to those
from wild-type mice, indicating that there is no significant role of
EBI3 in the induction of IFNc from NK and NKT cells after Lm-
Ova infection. Ly6C+CD11bhi dendritic cells, also known as Tip-
DC, suppress the dissemination of Lm [28,29]. We observed
comparable percentages of the Ly6C+CD11bhi DC in p352/2,
EBI32/2 as well as p352/2 EBI32/2 mice with that of wild-type
mice (Figure 4B). Therefore, the induction of Tip-DC was likely
normal in mice lacking p35, EBI3, or both in this experimental
setting.
NK, NKT, and cd T cells represent additional sources of innate
Th1 and Th17 cytokines that could be potentially released
following Lm infection. To investigate the contributions of the
cellular subsets, we measured the production of IFNc, IL-17, and
IL-22 from splenocytes obtained three days after Lm-Ova
infection. As depicted in Figure 4C, p352/2 mice as well as
p352/2 EBI32/2 mice showed significantly diminished IFNc
Figure 2. Increased pathogen-specific Th17 responses in the
absence of IL-12p35 and IL-27EBI3. C57BL/6 (WT) or the indicated
strains of mice (n = 5 per group) were intravenously infected with
2.56104 Lm-Ova on day 0. Seven days later, lymphoid cells from the
spleen were obtained and CD4+ T cells expressing IFNc and IL-17 were
measured by intracellular staining after stimulation with LLO190–201 (A
and B). The lymphoid cells from the spleen were stimulated with
LLO190–201 peptide for three days, and the concentrations of IFNc, IL-17
and IL-22 in the supernatant were measured by ELISA (C). Bars in B are
mean 6 SEM. Values in C are mean 6 SEM. Data shown are
representative of two independent experiments. *,p,0.05; **,p,0.01
in comparison with WT group. #,p,0.05; ##,p,0.01 in comparison
with p352/2 group.
doi:10.1371/journal.ppat.1003628.g002
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while EBI32/2 mice showed comparable IFNc production. In
contrast, the amounts of IL-17 in the supernatant were higher in
EBI32/2 and p352/2 EBI32/2 mice compared with those of
wild-type mice. The IL-22 production was higher in p352/2 and
p352/2 EBI32/2 mice. Collectively, these data suggest that the
regulation of Th1 and Th17 cytokines by innate immune cells is
also under the control of multiple IL-12 family cytokines.
p352/2EBI32/2 mice are resistant to L. monocytogenes
infection
We next addressed the differential roles of the IL-12 family
cytokines in host defense against Lm infection. Wild-type, p352/2,
EBI32/2, or p352/2EBI32/2 mice were intravenously infected
with Lm-Ova and bacterial burden in the livers and spleens were
measured three days later. As expected, p352/2 mice showed
higher bacterial burden in the livers compared to wild-type
Figure 3. Pathogen-specific CD8+ T cell responses in the absence of IL-12p35 and IL-27EBI3. C57BL/6 (WT) or the indicated strains of mice
(n = 5 per group) were intravenously infected with 2.56104 Lm-Ova on day 0. Seven days later, lymphoid cells from the spleen were obtained and
CD8+ T cells expressing IFNc and granzyme B were measured by intracellular staining after stimulation with SIINFEKL (A and B). CD8+ T cells
expressing T cell receptors specific to Ova were analyzed by staining with SIINFEKL-loaded Kb tetramer (B). The lymphoid cells from the spleen were
stimulated with SIINFEKL peptide for three days, and the concentrations of IFNc, IL-17 and IL-22 in the supernatant were measured by ELISA (C). Bars
in B are mean 6 SEM. Values in C are mean 6 SEM. Data shown are representative of two independent experiments. *,p,0.05; **,p,0.01 in
comparison with WT group. #,p,0.05; ##,p,0.01 in comparison with p352/2 group.
doi:10.1371/journal.ppat.1003628.g003
Figure 4. Enhanced production of Th17 cytokines in the p352/2EBI32/2 mice during the early phase of infection with L.
monocytogenes. C57BL/6 (WT) or the indicated strains of mice (n = 3 per group) were intravenously infected with 2.56104 Lm-Ova on day 0. Two to
three days later, lymphoid cells were analyzed for the production of IFNc by NK and NKT cells (A), or for the frequency of CD11b+Ly6C+ Tip DC (B). The
production of IFNc, IL-17, IL-17F and IL-22 by the splenocytes obtained three days after the infection was measured (C). Values are mean 6 SD. Data
shown are representative of two independent experiments. *,p,0.05; **,p,0.01 in comparison with WT group.
doi:10.1371/journal.ppat.1003628.g004
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controls (Figure 5A). We observed significantly less bacterial
burden in the livers of EBI32/2 mice compared with those from
wild-type, indicating that EBI3 is not required for the host defense
against the infection. To our surprise, the bacterial burden in the
livers of p352/2EBI32/2 mice was significantly lower than that of
p352/2 mice, to levels comparable to EBI32/2 mice (Figure 5A).
Within the spleens, p352/2EBI32/2 mice exhibited significantly
lower bacterial burden compared to p352/2 mice; however, there
was no evident difference in bacterial burden between wild-type
and EBI32/2 or p352/2EBI32/2 mice (Figure S1A).
We also measured bacterial burden 7 days after infection and
found that p352/2 mice failed to control bacterial growth with
significantly higher levels of bacteria in the livers compared to
wild-type animals (Figure 5B). However, EBI32/2 as well as
p352/2 EBI32/2 mice showed comparable levels of bacteria in
the livers compared to wild-type mice (Figure 5B). We also
observed similar pattern of bacterial burdens in the spleens of these
mice (Figure S1B). Therefore, the bacterial resistance observed at
day 3 largely remained intact by day 7 post infection. Collectively,
these findings demonstrate that EBI3-deficiency conferred resis-
tance to Lm-Ova infection in the absence of IL12p35, indicative of
possible antagonistic function of IL-12p35 and IL-27EBI3 in host
defense to the intracellular bacterial infection. Furthermore, in the
absence of IL-12p35, IL-27EBI3 likely exerts strong immunosup-
pressive activity and thus mediates immune evasion of the Lm in
vivo.
IL-17 and IL-22 mediate anti-Listeria immunity in the
absence of IL-12p35
The enhanced production of IL-17 and IL-22 we observed in
p352/2EBI32/2 mice by both innate and adaptive immune
compartments led us to hypothesize that the induction of the
Th17 cytokines might be responsible for the observed resistance
of p352/2EBI32/2 mice against Lm-Ova infection. To test this
hypothesis, we infected p352/2EBI32/2 mice with Lm-Ova
and then injected anti-IL-17 or control Ab. Notably, the
bacterial burden in the livers of the mice receiving anti-IL-17
showed a modest but significant increase (8 times higher) compared
with that of the control Ab group; however the burden was still
substantially lower than that observed in p352/2 mice (Figure 6A).
This result demonstrates that the upregulated production of IL-
17, at least in part, contributed to the observed resistance of
p352/2EBI32/2 mice to Lm-Ova infection.
Based on our findings, we hypothesized that IL-17-producing
cells suppress the growth of Lm, especially in the absence of IL-
12p35. To address this point, we investigated if Lm-specific Th17
cells are sufficient to limit the growth of Lm in the absence of IL-
12-mediated innate and adaptive immunity. To obtain Lm-
specific Th17 cells, we first isolated lymphoid cells from IL-17Frfp
mice [30] after immunization with LLO190–201 emulsified in CFA
and then restimulated them with peptide in the presence of IL-23,
IL-1b and anti-IFNc to specifically expand the Th17 population
[31]. After 5 days culture, we sorted RFP+ CD4+ cells (Figure 6B;
.80% IL-17+ and ,15% IFNc+), and transferred them i.v. into
p352/2 mice. Wild-type and p352/2 mice receiving no cells were
used as controls. All mice were then infected with Lm-Ova, and
the bacterial burden in the liver was measured 7 days post
infection. As shown in Figure 6C, the p352/2 mice receiving the
RFP+ CD4+ T cells showed significantly less bacterial load in the
liver compared to p352/2 mice receiving no cells (26.8 times
lower), although the bacterial burden in the former group was still
higher than that of the wild-type mice.
These results demonstrated that Lm-specific Th17 cells are
protective against Lm-Ova in the absence of IL-12p35; however, it
is possible that small population of IFNc-producers among the
RFP+ donor T cells (,15%) mediated this protection. To rule out
this possibility and to further determine the protective immunity
mediated by IL-17 and IL-22, we next examined if administration
of recombinant IL-17 or IL-22 mediates host defense against Lm-
Ova in the absence of IL-12p35. As depicted in Figure 7, p352/2
mice treated with IL-17 or IL-22 alone showed a slightly lower,
but not statistically significant, bacterial load in the liver than
saline-treated mice. Notably, administration of both cytokines
induced a significantly lower bacterial burden in the liver than
saline-, IL-17- or IL-22-treated p352/2 mice (29.5 times less than
saline-treated mice). Administration of IL-17 and IL-22, however,
did not fully restore the resistance of p352/2 mice, since the
bacterial load was still higher than that of wild-type mice (Figure 7
and Figure S2). The inhibition of bacterial growth by exogenous
IL-17 or IL-22 was more evident in the bacterial load in the
spleens (Figure S2). Taken together, these results indicate that the
Th17 cytokines IL-17 and IL-22 act synergistically to induce
protective anti-Listeria immunity in the absence of IL-12p35.
Figure 5. p352/2EBI32/2 mice are resistant to the infection with L. monocytogenes. C57BL/6 (WT) or the indicated strains of mice (n = 4–5
per group) were intravenously infected with 2.56104 Lm-Ova on day 0. Three (A) or seven (B) days later, the bacterial burden in the livers of the
infected mice was analyzed by measuring colony-forming unit. Bars are mean values. Data shown are representative of three independent
experiments. *, p,0.05 and **, p,0.01 in comparison between two indicated groups.
doi:10.1371/journal.ppat.1003628.g005
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Discussion
In this study, we comparatively analyzed the contribution of IL-
12p35 and IL-27EBI3 to the host defense against the intracellular
pathogen Lm. We demonstrate that, although p352/2 mice failed
to control bacterial growth, mice deficient in both p35 and EBI3
had no such defect in controlling bacterial growth. Our study also
revealed that IL-17 is involved in the protective immunity in
p352/2EBI32/2 mice. Furthermore, administration of Th17 cells
as well as recombinant IL-17 and IL-22 significantly suppressed
bacterial growth in p352/2 mice. These findings strongly suggest
that Lm utilizes IL-27EBI3 to escape Th17-mediated immune
surveillance in IL-12p35-deficient mice. Thus, the present study
unveils a previously unappreciated immune escape mechanism of
intracellular bacteria through IL-27EBI3, and that Th17 responses
play an important role in intracellular bacterial infection,
especially in the absence of IL-12 and Th1-mediated immunity.
NK cells, NKT cells and Tip-DC are well known innate effector
cells that suppress bacterial growth during the early phase of Lm
infection [28,29]. IL-12 is required for the induction of IFNc from
NK and NKT cells which then mediates the recruitment of Tip-
DC. Comparative analysis between p352/2 and p352/2 EBI32/2
mice showed no apparent difference in the activation of NK and
NKT cells and the frequency of Tip-DC. In addition, the
percentages of effector CD8+ T cells expressing granzyme B were
similar between p352/2 and p352/2EBI32/2 mice. Moreover,
although IL-27 has been reported to drive the differentiation of IL-
10 producing CD4+ T cells [18,19,20], we observed comparable
expression of the Il10 transcript between wild-type and EBI32/2
mice after Lm-Ova infection (data not shown). Therefore, we
conclude that the increased resistance to Lm in p352/2EBI32/2
mice is not due to the enhanced activity of these innate immune
cells nor CD8+ T cells.
Accumulating evidence suggests that some of the Th1 cells
recruited to inflamed tissues are actually derived from Th17 cells
[32,33]. However, we observed that very few LLO-specific IFNc-
producing CD4+ T cells in wild-type mice after Lm infection co-
expressed IL-17. In addition, LLO-specific, IFNc-producing
CD4+ T cells in IL-17FCre6Rosa26eYFP mice after Lm infection
were .99% YFP-negative (data not shown), indicating that Th1
cells do not originate from Th17 cells in this model.
Notably, we observed increased production of IL-17 and IL-22
by innate immune cells, presumably cd T cells [24,34], as well as
Lm-Ova-specific CD4+ T and CD8+ T cells in p352/2EBI32/2
mice. IL-22 is a Th17 cytokine that induces a series of anti-
microbial peptides upon infection [4,5,35,36]. The mechanism of
protection by these Th17 cytokines, however, significantly differs
Figure 6. A role for IL-17 and Th17 cells on the resistance of p352/2EBI32/2 mice against L. monocytogenes infection. A, C57BL/6 (WT)
or the indicated strains of mice (n = 4 per group) were intravenously infected with 2.56104 Lm-Ova on day 0. The mice were i.p. injected with 100 mg
of anti-IL-17 or rat IgG on day 0, 2, 4. Seven days after the infection, bacterial burden in the livers of the infected mice was determined by measuring
colony-forming unit. *, p,0.05 in comparison with rat IgG-treated group. B and C, IL-17Frfp reporter mice were s.c. immunized with LLO peptide
emulsified in CFA. Seven days later, lymphoid cells from spleen and draining lymph nodes of the immunized mice were isolated and stimulated with
the LLO peptide in the presence of IL-23 (50 ng/ml), IL-1b (10 ng/ml) and anti-IFNc for 5 days. CD4+ RFP+ cells were isolated by flow cytometry, and
the expression of IL-17 and IFNc was measured by intracellular staining (B). The sorted Th17 cells (56105 cells per transfer) were i.v. transferred into
p352/2 mice, followed by i.v. infection with 2.56104 Lm-Ova. WT or p352/2 mice without the cell transfer were used as controls. Seven days after
infection, bacterial burden in the liver was measured (C). Data shown are representative of two independent experiments. *, p,0.05 in comparison
with p352/2 mice without Th17 cell transfer.
doi:10.1371/journal.ppat.1003628.g006
Figure 7. IL-17 and IL-22 cooperatively promote protective
immunity against L. monocytogenes infection in p352/2 mice. A,
C57BL/6 (WT) or groups of p352/2 mice (n = 5 per group) were
intravenously infected with 2.56104 Lm-Ova on day 0. Some of the
p352/2 mice were i.p. injected with 1 mg of recombinant IL-17, IL-22, or
both on day 0, 2, 4. Seven days after the infection, bacterial burden in
the livers of the infected mice was determined by measuring colony-
forming unit. Bars are mean values. *, p,0.05 in comparison between
two indicated groups.
doi:10.1371/journal.ppat.1003628.g007
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from that of IFNc due to the distribution of receptors and
differential downstream targets. IFNc mediates protective immu-
nity by multiple mechanisms including the induction of iNOS and
autophagy [21,37,38], whereas IL-17 does so possibly through
neutrophil recruitment and by enhancing cross-presentation of
bacterial antigens [24,34]. In the present study, the amounts of IL-
17 and IL-22 produced by innate cells and the pathogen-specific T
cells were significantly increased in p352/2EBI32/2 mice.
Furthermore, exogenous IL-17 and IL-22 synergistically induced
protective immunity in p35-deficient mice, while each cytokine
individually could only invoke marginal protection. Supporting
this notion, it has been documented that IL-17 and IL-22
synergistically induce the expression of antimicrobial peptides
[36]. Conversely, IL-22 has been shown to be dispensable for the
clearance of Lm in p35-sufficient mice [39]. Our present work
combined with other reports then suggests that, in the absence of
IL-12-mediated protective immunity, Th17 cytokines IL-17 and
IL-22 cooperatively inhibit the growth of Lm and are negatively
regulated by EBI3. Importantly, since the bacterial burden in
p352/2 mice treated with exogenous IL-17 and IL-22 was still
higher than that of wild-type mice, undefined alternative
protective mechanism may still exist.
One can assume that the difference between p352/2 mice and
p352/2EBI32/2 mice in anti-Lm immunity could be due to the
effect of IL-35, which is composed of p35 and EBI3 [40]. Given
that p352/2 mice cannot produce IL-12 and IL-35, and that
p352/2EBI32/2 mice cannot produce IL-12, IL-35 and IL-27,
the only cytokine that is lacking in the latter mice compared with
the former mice is IL-27. Recent studies have shown that the
other subunit of IL-27, IL-27p28, can be secreted in the absence
of EBI3 to act as an antagonist of gp130 [15,41,42] or
alternatively form a heterodimer with Cytokine-Like Factor 1
(p28/CLF) to promote NK and T cell activity [43]. Hence, EBI3-
deficiency may lead to the production of p28 and p28/CLF,
which may exert biological activities independently of IL-27. The
role of p28 subunit of IL-27 during host defense in the present
study is not clear. Future studies with p28-deficient mice will be
important for a complete understanding on the mechanism by
which EBI3 regulates protective immunity to intracellular
pathogens.
IL-27 has been shown to trigger preliminary Th1 responses, where
mice deficient in the IL-27 receptor (WSX-12/2; TCCR2/2) are
more susceptible to Leishmania major [12] and Lm infection [13] due to
decreased Th1 responses. On the contrary, WSX-12/2 mice
generate more IFNc-producing CD4+ T cells than wild-type mice
after infection with Toxoplasma gondii [14], indicating that IL-27 signal
is not necessary for the generation of Th1 immunity to the infection.
Therefore the effect of IL-27 on pathogen-specific Th1 response is
likely dependent on the infectious agents. It is not clear why IL-
27EBI32/2 mice in the present study did not recapitulate the
phenotype of IL-27R2/2 mice in a previous study [13]. It is possible
that the route of infection (intravenous versus subcutaneous) results in
distinct immune responses to Lm. Alternatively, it is possible that the
phenotype of EBI32/2mice described in this study may in fact be IL-
27 independent and instead mediated through IL-27p28 [42,44,45].
Interestingly, fundamental differences have also been reported
between WSX-12/2 and EBI32/2 mice. For instance, WSX-12/2
mice exhibited enhanced liver inflammation, whereas EBI32/2mice
showed reduced liver inflammation in the same Con A-induced
hepatitis animal model [46,47]. Moreover, while T cells from WSX-
12/2 mice produce less IFNc, T cells from EBI32/2 mice produce
higher IFNc and less IL-4 than wild-type T cells [12,13,48]. Further
study is needed to demonstrate the mechanism of these differences in
the regulation of infectious and inflammatory diseases between the
EBI3 and IL-27 receptor signaling pathways.
Collectively our findings demonstrate that the immune system
produces IL-12 to suppress bacterial growth upon infection while
Lm utilizes another host immune component, EBI3, to escape
immune surveillance. Increased susceptibility to intracellular
pathogens in patients with deficiency in IL-12 or its receptor has
been demonstrated [49,50]. Based on our findings, blockade of
EBI3 may provide a new therapeutic approach for the treatment




All the animal experiments were performed in accordance with
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health and with the permission of the
American Association for the Assessment and Accreditation of
Laboratory Animal Care. The protocol was reviewed and
approved by the Institutional Animal Care and Use Committee
of MD Anderson Cancer Center (identification number: 10-04-
09833) and University of Texas Health Science Center at Houston
(identification number: HSC-AWC-12-008).
Mice
C57BL/6 and IL-12p352/2 mice were purchased from the
Jackson Laboratory. IL-27EBI32/2 mice were generated as
described previously [48]. Double-deficient mice (p352/2EBI32/2)
were obtained by crossing IL-12p352/2 and IL-27EBI32/2 mice.
IL-17Frfp-reporter mice were generated as described previously [30].
All mice were kept under specific pathogens-free condition. The
animal experiments were performed at the age of 6–12 weeks.
Stimulation of bone marrow-derived dendritic cells (BM-
DC) and macrophages (BM-M)
Bone marrow cells from femurs and tibia of C57BL/6 mice
were cultured with 10% FBS supplemented RPMI containing
GM-CSF or M-CSF for 6 days. For irradiation, log-phase cultured
Lm-Ova were exposed to 300 K rad of c-irradiation. After
extensive washing, BM-DC and BM-M cells were incubated with
the irradiated Lm-Ova at the ratio of 1:10. As controls, LPS
(100 ng/ml) and Pam3CysSK4 (Pam; 1 mg/ml) were added in the
culture. Four hours after the stimulation, cells were harvested and
resuspended in Trizol for mRNA expression analysis.
Infection with Listeria monocytogenes
An erythromycin resistant strain of Lm-Ova was grown in brain
heart infusion media supplemented with 5 mg/ml erythromycin
[51]. The bacteria were harvested at mid-log growth phase and
were intravenously injected into animals (2.56104 CFU/mouse).
In some experiments, mice were intraperitoneally administered
recombinant murine IL-17, IL-22 (Peprotech), or both (1 mg/
injection) on day 0, 2, 4 after infection. Three or seven days after
infection, spleens and livers of the infected mice were harvested.
Bacterial burdens were determined by measuring colony forming
unit, as described previously [52]. Splenocytes were stimulated
with SIINFEKL peptide or LLO190–201 peptide overnight for
intracellular cytokine staining, or 3 days for ELISA analysis [52].
In some experiments, splenocytes were resuspended in Trizol for
mRNA expression analysis.
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Antibodies used for flow cytometric analysis
The following antibodies were used for cell surface and
intracellular staining; PerCPCy5-5- or FICT-labeled anti-TCRb
(H57-597), PerCPCy5-5-labeled anti-CD4 (GK1.5), Alexa 488-
labeled anti-CD8 (5H10-1), APC-labeled anti-CD11b (M1/70)
from Biolegnd; PE- or Alexa 488-labeled anti-IFNc (XMG1.2),
PE-labeled anti-IL-17 (clone TC11-18H10), Alexa 647-labeled
anti-GranzymeB (GB11) FITC- or PerCPCy5.5-labeled anti-
NK1.1 (PK136), PerCPCy5-5-labeled anti-Ly6C (AL21) from
BD Biosciences. For intracellular staining, cells were incubated
with permeabilization buffer (BD Biosciences), and then further
stained with intracellular staining Abs described above. These cells
were analyzed by using LSRII flow cytometer (BD Bioscience) and
Flowjo software.
Real-time PCR analysis for mRNA expression
Total RNA was prepared from splenocytes with TriZol reagent
(Invitrogen). Complementary DNA (cDNA) was synthesized with
Superscript reverse transcriptase and oligo(dT) primers (Invitro-
gen), and gene expression was examined with a Bio-Rad iCycler
Optical System with iQ SYBR green real-time PCR kit (Bio-Rad
Laboratories). The data were normalized to Actb reference. The
following primer pairs were used: ActB: F-GAC GGC CAG GTC
ATC ACT ATT G and R-AGG AAG GCT GGA AAA GAG
CC; Ifng: F-GAT GCA TTC ATG AGT ATT GCC AAG T and
R-GTG GAC CAC TCG GAT GAG CTC; Il17: F-CTG GAG
GAT AAC ACT GTG AGA GT and R-TGC TGA ATG GCG
ACG GAG TTC; Il17f: F-CTG GAG GAT AAC ACT GTG
AGA GT-39 and R-TGC TGA ATG GCG ACG GAG TTC;
Il22: F-CAT GCA GGA GGT GGT ACC TT and R-CAG ACG
CAA GCA TTT CTC AG; Il10: F-ATA ACT GCA CCC ACT
TCC CAG TC and R-CCC AAG TAA CCC TTA AAG TCC
TGC; Ebi3: F-TCC CCG AGG TGC AAC TGT TCT CC and
R-GGT CCT GAG CTG ACA CCT GG. Primers for p35, p40,
p19 were described previously [53].
Adoptive transfer study
To obtain IL-17-producing CD4+ T cells specific for Lm-Ova,
we s.c. immunized IL-17Frfp-reporter mice with LLO peptide in
CFA. A week later, lymphoid cells from the draining lymph nodes
and spleen were pooled and restimulated with the same peptide in
the presence of IL-23 (50 ng/ml) and IL-1b (10 ng/ml) plus anti-
IFNc (5 mg/ml; XMG1.2) for five days. The cells were stained
with APC-labeled anti-CD4, and APC-positive and RFP-positive
cells were sorted by using FACS-Influx (BD Biosciences). 2.56105
sorted cells/mouse were intravenously injected into IL-12p352/2
mice followed by Lm-Ova inoculation and analysis of bacterial
burden, as described above.
Statistical analysis
The Student t test was used to assess the statistical values. P
values were determined, and error bars represent standard error of
the mean (SEM) or standard deviation (SD).
Supporting Information
Figure S1 Bacterial load in the spleens of p352/2 and
EBI32/2 mice after infection with L. monocytogenes.
C57BL/6 (WT) or the indicated strains of mice (n = 4–5 per
group) were intravenously infected with 2.56104 Lm-Ova on day
0. Three (A) or seven (B) days later, the bacterial burden in the
spleens of the infected mice was analyzed by measuring colony-
forming unit. Bars are mean values. Data shown are representative
of three independent experiments. *, p,0.05 and **, p,0.01 in
comparison between two indicated groups.
(PDF)
Figure S2 Bacterial load in the spleens of p352/2 mice
treated with IL-17 or IL-22. A, C57BL/6 (WT) or groups of
p352/2 mice (n= 5 per group) were intravenously infected with
2.56104 Lm-Ova on day 0. Some of the p352/2 mice were i.p.
injected with 1 mg of recombinant IL-17, IL-22, or both on day 0,
2, 4. Seven days after the infection, bacterial burden in the spleens
of the infected mice was determined by measuring colony-forming
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